Cargando…
The Good, the Bad and the New about Uric Acid in Cancer
SIMPLE SUMMARY: The concentration of uric acid in blood is sex-, age- and diet-dependent and is maintained close to its maximal solubility, indicating that it plays some important role. Indeed, it has been demonstrated that, at physiological concentrations, uric acid is a powerful antioxidant and is...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9561999/ https://www.ncbi.nlm.nih.gov/pubmed/36230882 http://dx.doi.org/10.3390/cancers14194959 |
_version_ | 1784808073103147008 |
---|---|
author | Allegrini, Simone Garcia-Gil, Mercedes Pesi, Rossana Camici, Marcella Tozzi, Maria Grazia |
author_facet | Allegrini, Simone Garcia-Gil, Mercedes Pesi, Rossana Camici, Marcella Tozzi, Maria Grazia |
author_sort | Allegrini, Simone |
collection | PubMed |
description | SIMPLE SUMMARY: The concentration of uric acid in blood is sex-, age- and diet-dependent and is maintained close to its maximal solubility, indicating that it plays some important role. Indeed, it has been demonstrated that, at physiological concentrations, uric acid is a powerful antioxidant and is a scavenger of singlet oxygen and radicals. At high intracellular concentration, uric acid has been demonstrated to act as a pro-oxidant molecule. Recently, uric acid has been reported to affect the properties of several proteins involved in metabolic regulation and signaling, and the relationship between uric acid and cancer has been extensively investigated. In this review, we present the most recent results on the positive and negative effects played by uric acid in cancer and some new findings and hypotheses about the implication of this metabolite in the pathogenesis of several diseases such as metabolic syndrome, diabetes, and inflammation, thus favoring the development of cancer. ABSTRACT: Uric acid is the final product of purine catabolism in man and apes. The serum concentration of uric acid is sex-, age- and diet-dependent and is maintained close to its maximal solubility, indicating that it plays some important role. Indeed, it has been demonstrated that, at physiological concentrations, uric acid is a powerful antioxidant, while at high intracellular concentrations, it is a pro-oxidant molecule. In this review, we describe the possible causes of uric acid accumulation or depletion and some of the metabolic and regulatory pathways it may impact. Particular attention has been given to fructose, which, because of the complex correlation between carbohydrate and nucleotide metabolism, causes uric acid accumulation. We also present recent results on the positive and negative effects played by uric acid in cancer and some new findings and hypotheses about the implication of this metabolite in a variety of signaling pathways, which can play a role in the pathogenesis of diseases such as metabolic syndrome, diabetes, and inflammation, thus favoring the development of cancer. The loss of uricase in Homo sapiens and great apes, although exposing these species to the potentially adverse effects of uric acid, appears to be associated with evolutionary advantages. |
format | Online Article Text |
id | pubmed-9561999 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-95619992022-10-15 The Good, the Bad and the New about Uric Acid in Cancer Allegrini, Simone Garcia-Gil, Mercedes Pesi, Rossana Camici, Marcella Tozzi, Maria Grazia Cancers (Basel) Review SIMPLE SUMMARY: The concentration of uric acid in blood is sex-, age- and diet-dependent and is maintained close to its maximal solubility, indicating that it plays some important role. Indeed, it has been demonstrated that, at physiological concentrations, uric acid is a powerful antioxidant and is a scavenger of singlet oxygen and radicals. At high intracellular concentration, uric acid has been demonstrated to act as a pro-oxidant molecule. Recently, uric acid has been reported to affect the properties of several proteins involved in metabolic regulation and signaling, and the relationship between uric acid and cancer has been extensively investigated. In this review, we present the most recent results on the positive and negative effects played by uric acid in cancer and some new findings and hypotheses about the implication of this metabolite in the pathogenesis of several diseases such as metabolic syndrome, diabetes, and inflammation, thus favoring the development of cancer. ABSTRACT: Uric acid is the final product of purine catabolism in man and apes. The serum concentration of uric acid is sex-, age- and diet-dependent and is maintained close to its maximal solubility, indicating that it plays some important role. Indeed, it has been demonstrated that, at physiological concentrations, uric acid is a powerful antioxidant, while at high intracellular concentrations, it is a pro-oxidant molecule. In this review, we describe the possible causes of uric acid accumulation or depletion and some of the metabolic and regulatory pathways it may impact. Particular attention has been given to fructose, which, because of the complex correlation between carbohydrate and nucleotide metabolism, causes uric acid accumulation. We also present recent results on the positive and negative effects played by uric acid in cancer and some new findings and hypotheses about the implication of this metabolite in a variety of signaling pathways, which can play a role in the pathogenesis of diseases such as metabolic syndrome, diabetes, and inflammation, thus favoring the development of cancer. The loss of uricase in Homo sapiens and great apes, although exposing these species to the potentially adverse effects of uric acid, appears to be associated with evolutionary advantages. MDPI 2022-10-10 /pmc/articles/PMC9561999/ /pubmed/36230882 http://dx.doi.org/10.3390/cancers14194959 Text en © 2022 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Review Allegrini, Simone Garcia-Gil, Mercedes Pesi, Rossana Camici, Marcella Tozzi, Maria Grazia The Good, the Bad and the New about Uric Acid in Cancer |
title | The Good, the Bad and the New about Uric Acid in Cancer |
title_full | The Good, the Bad and the New about Uric Acid in Cancer |
title_fullStr | The Good, the Bad and the New about Uric Acid in Cancer |
title_full_unstemmed | The Good, the Bad and the New about Uric Acid in Cancer |
title_short | The Good, the Bad and the New about Uric Acid in Cancer |
title_sort | good, the bad and the new about uric acid in cancer |
topic | Review |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9561999/ https://www.ncbi.nlm.nih.gov/pubmed/36230882 http://dx.doi.org/10.3390/cancers14194959 |
work_keys_str_mv | AT allegrinisimone thegoodthebadandthenewabouturicacidincancer AT garciagilmercedes thegoodthebadandthenewabouturicacidincancer AT pesirossana thegoodthebadandthenewabouturicacidincancer AT camicimarcella thegoodthebadandthenewabouturicacidincancer AT tozzimariagrazia thegoodthebadandthenewabouturicacidincancer AT allegrinisimone goodthebadandthenewabouturicacidincancer AT garciagilmercedes goodthebadandthenewabouturicacidincancer AT pesirossana goodthebadandthenewabouturicacidincancer AT camicimarcella goodthebadandthenewabouturicacidincancer AT tozzimariagrazia goodthebadandthenewabouturicacidincancer |